Editorial Comment: Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control
Marcio Augusto Averbeck
International Brazilian Journal of Urology · 2020
doi:10.1590/s1677-5538.ibju.2020.02.10 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
There is increasing evidence for a possible causal association between the chronic use of anticholinergics and the risk of developing dementia. The inherent limitation for establishing such causal nexus is precisely the fact that the prevalence of overactive bladder (OAB) symptoms and the prescription of antimuscarinics tends to increase in older individuals, exactly in the same age groups in which the incidence of dementia is higher (1).
Abstract licence: CC BY
References2
- 1.
1 more reference, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.